BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 444682)

  • 1. [Circulating immune complexes of patients with malignant lymphomas (author's transl)].
    Sodomann CP; Schmidt H; Havemann K
    Blut; 1979 Jun; 38(6):435-46. PubMed ID: 444682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and prognosis in human malignant lymphoma, a prospective study.
    Heier HE; Landaas TO; Marton PF
    Int J Cancer; 1979 Mar; 23(3):292-8. PubMed ID: 437911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of circulating immune-complexes as prognostic indicators of lympho-reticular and mesenchymal malignancies in children.
    Aziz M; Dass TK; Rattan A
    J Trop Pediatr; 1992 Aug; 38(4):185-8. PubMed ID: 1527815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Tomasević Z; Jelić S
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in Hodgkin's disease.
    Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC
    Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes in Hodgkin's disease.
    Akolkar PN; Advani SH; Gothoskar BP
    Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1993; 40(2):87-91. PubMed ID: 8350960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of serum complement components and plasma C3d in patients with malignant lymphoma: relation to the stage of the tumor and circulating immune complexes.
    Heier HE; Carpentier NA; Lambert PH; Godal T
    Int J Cancer; 1978 Jun; 21(6):695-9. PubMed ID: 669852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of splenectomy on the levels of circulating immune complexes (CIC) in Hodgkin's disease (HD).
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1987; 34(1):89-93. PubMed ID: 3561608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clincal study on serum immunoglobulin E (IgE) concentrations in patients with malignant lymphoma with special reference to Hodgkin's disease (author's transl)].
    Kimura I; Onoshi T; Tanizaki Y; Ueda N
    Rinsho Ketsueki; 1975 Dec; 16(12):1117-23. PubMed ID: 1240980
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms.
    Queen WD; Bharwani N; Phillips EA; Ruether BA; Phillips TM; Jerry LM
    Oncology; 1989; 46(1):14-25. PubMed ID: 2915889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in patients with malignant lymphomas and solid tumors.
    Heier HE; Carpentier N; Lange G; Lambert PH; Godal T
    Int J Cancer; 1977 Dec; 20(6):887-94. PubMed ID: 338514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precipitable immune complexes in Hodgkin's disease.
    Euler HH; Béress R; Moldenhauer I; Löffler H
    Int J Cancer; 1983 Oct; 32(4):437-41. PubMed ID: 6618706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating immune complexes in malignant tumors].
    Savina NP
    Sov Med; 1989; (8):8-10. PubMed ID: 2814673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients.
    Velardi A; Spinozzi F; Rambotti P; Tabilio A; Losito A; Zampi I; Cernetti C; Martelli MF; Grignani F; Davis S
    J Clin Oncol; 1983 Feb; 1(2):117-25. PubMed ID: 6668495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of circulating immune complexes in some diseases associated with platelets hyperdestruction process (author's transl)].
    Goudemand J; Santoro F
    Sem Hop; 1979 Jan 18-25; 55(3-4):198-202. PubMed ID: 219529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of circulating immune complexes in some diseases associated with a platelets hyperdestruction process (author's transl)].
    Goudemand J; Santoro F
    Pathol Biol (Paris); 1978 Oct; 26(7):435-9. PubMed ID: 372899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levels of immune complexes in fresh and frozen serum and plasma detected by precipitation with polyethylene glycol in patients with malignant diseases].
    Kovcin V; Juranić Z; Babović N; Tomasević Z
    Srp Arh Celok Lek; 1997; 125(5-6):154-6. PubMed ID: 9265236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on circulating immune complexes. III: Kinetics of the immunoglobulin class of circulating immune complexes in systemic lupus erythematosus.
    Miura Y
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):201-9. PubMed ID: 2739119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.